325 related articles for article (PubMed ID: 9545110)
1. Increased serum concentration of interleukin-5 in patients with Graves' disease and Hashimoto's thyroiditis.
Hidaka Y; Okumura M; Shimaoka Y; Takeoka K; Tada H; Amino N
Thyroid; 1998 Mar; 8(3):235-9. PubMed ID: 9545110
[TBL] [Abstract][Full Text] [Related]
2. Increased serum concentration of interleukin-12 in patients with silent thyroiditis and Graves' disease.
Hidaka Y; Okumura M; Fukata S; Shimaoka Y; Takeoka K; Tada H; Kuma K; Amino N
Thyroid; 1999 Feb; 9(2):149-53. PubMed ID: 10090314
[TBL] [Abstract][Full Text] [Related]
3. Increased serum concentration of soluble CD30 in patients with Graves' disease and Hashimoto's thyroiditis.
Okumura M; Hidaka Y; Kuroda S; Takeoka K; Tada H; Amino N
J Clin Endocrinol Metab; 1997 Jun; 82(6):1757-60. PubMed ID: 9177377
[TBL] [Abstract][Full Text] [Related]
4. Th1 and Th2 serum cytokine profiles characterize patients with Hashimoto's thyroiditis (Th1) and Graves' disease (Th2).
Phenekos C; Vryonidou A; Gritzapis AD; Baxevanis CN; Goula M; Papamichail M
Neuroimmunomodulation; 2004; 11(4):209-13. PubMed ID: 15249726
[TBL] [Abstract][Full Text] [Related]
5. Association of seasonal allergic rhinitis is high in Graves' disease and low in painless thyroiditis.
Amino N; Hidaka Y; Takano T; Izumi Y; Tatsumi KI; Nakata Y
Thyroid; 2003 Aug; 13(8):811-4. PubMed ID: 14558923
[TBL] [Abstract][Full Text] [Related]
6. Influence of thyroxine on serum soluble interleukin-2 receptor alpha levels in thyroid disorders.
Zwirska-Korczala K; Berdowska A; Jochem J; Sitkiewicz A; Birkner E; Polaniak R; Jedrzejowska-Szypułka H; Korzonek-Szlacheta I
J Clin Pharm Ther; 2004 Apr; 29(2):151-6. PubMed ID: 15068404
[TBL] [Abstract][Full Text] [Related]
7. Activated (Ia+) T-cells and their subsets in Graves' disease and Hashimoto's thyroiditis using dual laser flow microfluorocytometric analysis.
Chan JY; Walfish PG
Mol Biol Med; 1986 Feb; 3(1):99-112. PubMed ID: 3083193
[TBL] [Abstract][Full Text] [Related]
8. Serum interferon gamma levels in autoimmune thyroid disease.
Matsubayashi S; Kasuga Y; Sakatsume Y; Akasu F; Volpé R
Clin Invest Med; 1990 Oct; 13(5):271-4. PubMed ID: 2125901
[TBL] [Abstract][Full Text] [Related]
9. In vitro production of interferon-gamma by peripheral blood from patients with Graves' disease, Hashimoto's thyroiditis and rheumatoid arthritis.
Matsubayashi S; Akasu F; Kasuga Y; Snow K; Keystone E; Volpé R
Clin Exp Immunol; 1990 Oct; 82(1):63-8. PubMed ID: 1976464
[TBL] [Abstract][Full Text] [Related]
10. Association of HLA antigen and restriction fragment length polymorphism of T cell receptor beta-chain gene with Graves' disease and Hashimoto's thyroiditis.
Ito M; Tanimoto M; Kamura H; Yoneda M; Morishima Y; Yamauchi K; Itatsu T; Takatsuki K; Saito H
J Clin Endocrinol Metab; 1989 Jul; 69(1):100-4. PubMed ID: 2567295
[TBL] [Abstract][Full Text] [Related]
11. Differential autoantibody responses to thyroid peroxidase in patients with Graves' disease and Hashimoto's thyroiditis.
Bermann M; Magee M; Koenig RJ; Kaplan MM; Arscott P; Maastricht J; Johnson J; Baker JR
J Clin Endocrinol Metab; 1993 Oct; 77(4):1098-101. PubMed ID: 8408460
[TBL] [Abstract][Full Text] [Related]
12. Production of IL-10 and IL-12 in CD40 and interleukin 4-activated mononuclear cells from patients with Graves' disease.
Itoh M; Uchimura K; Makino M; Kobayashi T; Hayashi R; Nagata M; Kakizawa H; Fujiwara K; Nagasaka A
Cytokine; 2000 Jun; 12(6):688-93. PubMed ID: 10843746
[TBL] [Abstract][Full Text] [Related]
13. Increased serum concentration of eosinophil-derived neurotoxin in patients with Graves' disease.
Hidaka Y; Kimura M; Izumi Y; Takano T; Tatsumi KI; Amino N
Thyroid; 2003 Feb; 13(2):129-32. PubMed ID: 12699586
[TBL] [Abstract][Full Text] [Related]
14. Increased levels of serum interleukin-18 in Graves' disease.
Miyauchi S; Matsuura B; Onji M
Thyroid; 2000 Sep; 10(9):815-9. PubMed ID: 11041460
[TBL] [Abstract][Full Text] [Related]
15. T lymphocyte subsets in autoimmune thyroid diseases and subacute thyroiditis detected with monoclonal antibodies.
Iwatani Y; Amino N; Mori H; Asari S; Izumiguchi Y; Kumahara Y; Miyai K
J Clin Endocrinol Metab; 1983 Feb; 56(2):251-4. PubMed ID: 6218181
[TBL] [Abstract][Full Text] [Related]
16. Opposite changes in serum soluble CD8 in patients at the active stages of Graves' and Hashimoto's diseases.
Watanabe M; Amino N; Hochito K; Watanabe K; Kuma K; Iwatani Y
Thyroid; 1997 Oct; 7(5):743-7. PubMed ID: 9349577
[TBL] [Abstract][Full Text] [Related]
17. Hashimoto's thyroiditis following Graves' disease.
Umar H; Muallima N; Adam JM; Sanusi H
Acta Med Indones; 2010 Jan; 42(1):31-5. PubMed ID: 20305330
[TBL] [Abstract][Full Text] [Related]
18. Activated (Ia+) T-lymphocytes and their subsets in autoimmune thyroid diseases: analysis by dual laser flow microfluorocytometry.
Chan JY; Walfish PG
J Clin Endocrinol Metab; 1986 Feb; 62(2):403-9. PubMed ID: 3484483
[TBL] [Abstract][Full Text] [Related]
19. Peripheral blood T-lymphocyte subsets in autoimmune thyroid disease.
Covas MI; Esquerda A; García-Rico A; Mahy N
J Investig Allergol Clin Immunol; 1992; 2(3):131-5. PubMed ID: 1342892
[TBL] [Abstract][Full Text] [Related]
20. Increased levels of serum interleukin-12 in Graves' disease.
Tamaru M; Matsuura B; Onji M
Eur J Endocrinol; 1999 Aug; 141(2):111-6. PubMed ID: 10427152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
